Global Migraine Drugs Market Research Report 2019

Table of Contents

1 Migraine Drugs Market Overview

• 1.1 Product Overview and Scope of Migraine Drugs
• 1.2 Migraine Drugs Segment by Type
  • 1.2.1 Global Migraine Drugs Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Sumatriptan
  • 1.2.3 Zolmitriptan
  • 1.2.4 Rizatriptan
  • 1.2.5 Others Drug
• 1.3 Migraine Drugs Segment by Application
  • 1.3.1 Migraine Drugs Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Household Use
  • 1.3.5 Others
• 1.4 Global Migraine Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global Migraine Drugs Revenue 2015-2026
  • 1.4.2 Global Migraine Drugs Sales 2015-2026
  • 1.4.3 Migraine Drugs Market Size by Region: 2020 Versus 2026

2 Global Migraine Drugs Market Competition by Manufacturers

• 2.1 Global Migraine Drugs Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Migraine Drugs Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Migraine Drugs Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Migraine Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 Migraine Drugs Market Competitive Situation and Trends
  • 2.5.1 Migraine Drugs Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Migraine Drugs Players (Opinion Leaders)

3 Migraine Drugs Retrospective Market Scenario by Region

• 3.1 Global Migraine Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Migraine Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Migraine Drugs Market Facts & Figures by Country
  • 3.3.1 North America Migraine Drugs Sales by Country
  • 3.3.2 North America Migraine Drugs Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Migraine Drugs Market Facts & Figures by Country
  • 3.4.1 Europe Migraine Drugs Sales by Country
  • 3.4.2 Europe Migraine Drugs Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Migraine Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Migraine Drugs Sales by Region
  • 3.5.2 Asia Pacific Migraine Drugs Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Migraine Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America Migraine Drugs Sales by Country
  • 3.6.2 Latin America Migraine Drugs Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Migraine Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Migraine Drugs Sales by Country
  • 3.7.2 Middle East and Africa Migraine Drugs Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Migraine Drugs Historic Market Analysis by Type

• 4.1 Global Migraine Drugs Sales Market Share by Type (2015-2020)
• 4.2 Global Migraine Drugs Revenue Market Share by Type (2015-2020)
• 4.3 Global Migraine Drugs Price Market Share by Type (2015-2020)
• 4.4 Global Migraine Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Migraine Drugs Historic Market Analysis by Application

• 5.1 Global Migraine Drugs Sales Market Share by Application (2015-2020)
• 5.2 Global Migraine Drugs Revenue Market Share by Application (2015-2020)
• 5.3 Global Migraine Drugs Price by Application (2015-2020)

6 Company Profiles and Key Figures in Migraine Drugs Business

• 6.1 Allergan
  • 6.1.1 Corporation Information
  • 6.1.2 Allergan Description, Business Overview and Total Revenue
  • 6.1.3 Allergan Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Allergan Products Offered
  • 6.1.5 Allergan Recent Development
• 6.2 Merck
  • 6.2.1 Merck Migraine Drugs Production Sites and Area Served
  • 6.2.2 Merck Description, Business Overview and Total Revenue
  • 6.2.3 Merck Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Merck Products Offered
  • 6.2.5 Merck Recent Development
• 6.3 Pfizer
  • 6.3.1 Pfizer Migraine Drugs Production Sites and Area Served
  • 6.3.2 Pfizer Description, Business Overview and Total Revenue
  • 6.3.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Pfizer Products Offered
  • 6.3.5 Pfizer Recent Development
• 6.4 Teva
  • 6.4.1 Teva Migraine Drugs Production Sites and Area Served
  • 6.4.2 Teva Description, Business Overview and Total Revenue
  • 6.4.3 Teva Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Teva Products Offered
  • 6.4.5 Teva Recent Development
• 6.5 Pfizer
  • 6.5.1 Pfizer Migraine Drugs Production Sites and Area Served
  • 6.5.2 Pfizer Description, Business Overview and Total Revenue
  • 6.5.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Pfizer Products Offered
  • 6.5.5 Pfizer Recent Development
• 6.6 Johnson & Johnson
  • 6.6.1 Johnson & Johnson Migraine Drugs Production Sites and Area Served
  • 6.6.2 Johnson & Johnson Description, Business Overview and Total Revenue
  • 6.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Johnson & Johnson Products Offered
  • 6.6.5 Johnson & Johnson Recent Development
• 6.7 Endo International
  • 6.6.1 Endo International Migraine Drugs Production Sites and Area Served
  • 6.6.2 Endo International Description, Business Overview and Total Revenue
  • 6.6.3 Endo International Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Endo International Products Offered
  • 6.7.5 Endo International Recent Development
• 6.8 GlaxoSmithKline
  • 6.8.1 GlaxoSmithKline Migraine Drugs Production Sites and Area Served
  • 6.8.2 GlaxoSmithKline Description, Business Overview and Total Revenue
  • 6.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 GlaxoSmithKline Products Offered
  • 6.8.5 GlaxoSmithKline Recent Development
• 6.9 Impax
  • 6.9.1 Impax Migraine Drugs Production Sites and Area Served
  • 6.9.2 Impax Description, Business Overview and Total Revenue
  • 6.9.3 Impax Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Impax Products Offered
  • 6.9.5 Impax Recent Development
• 6.10 Abbott
  • 6.10.1 Abbott Migraine Drugs Production Sites and Area Served
  • 6.10.2 Abbott Description, Business Overview and Total Revenue
  • 6.10.3 Abbott Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Abbott Products Offered
  • 6.10.5 Abbott Recent Development
• 6.11 Bayer
  • 6.11.1 Bayer Migraine Drugs Production Sites and Area Served
  • 6.11.2 Bayer Migraine Drugs Description, Business Overview and Total Revenue
  • 6.11.3 Bayer Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 Bayer Products Offered
  • 6.11.5 Bayer Recent Development
• 6.12 Eli Lilly
  • 6.12.1 Eli Lilly Migraine Drugs Production Sites and Area Served
  • 6.12.2 Eli Lilly Migraine Drugs Description, Business Overview and Total Revenue
  • 6.12.3 Eli Lilly Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.12.4 Eli Lilly Products Offered
  • 6.12.5 Eli Lilly Recent Development
• 6.13 Ethypharm
  • 6.13.1 Ethypharm Migraine Drugs Production Sites and Area Served
  • 6.13.2 Ethypharm Migraine Drugs Description, Business Overview and Total Revenue
  • 6.13.3 Ethypharm Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.13.4 Ethypharm Products Offered
  • 6.13.5 Ethypharm Recent Development
• 6.14 Kowa Pharmaceuticals America
  • 6.14.1 Kowa Pharmaceuticals America Migraine Drugs Production Sites and Area Served
  • 6.14.2 Kowa Pharmaceuticals America Migraine Drugs Description, Business Overview and Total Revenue
  • 6.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.14.4 Kowa Pharmaceuticals America Products Offered
  • 6.14.5 Kowa Pharmaceuticals America Recent Development
• 6.15 Winston Pharmaceuticals
  • 6.15.1 Winston Pharmaceuticals Migraine Drugs Production Sites and Area Served
  • 6.15.2 Winston Pharmaceuticals Migraine Drugs Description, Business Overview and Total Revenue
  • 6.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.15.4 Winston Pharmaceuticals Products Offered
  • 6.15.5 Winston Pharmaceuticals Recent Development
• 6.16 AstraZeneca
  • 6.16.1 AstraZeneca Migraine Drugs Production Sites and Area Served
  • 6.16.2 AstraZeneca Migraine Drugs Description, Business Overview and Total Revenue
  • 6.16.3 AstraZeneca Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
  • 6.16.4 AstraZeneca Products Offered
  • 6.16.5 AstraZeneca Recent Development

7 Migraine Drugs Manufacturing Cost Analysis

• 7.1 Migraine Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Migraine Drugs
• 7.4 Migraine Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Migraine Drugs Distributors List
• 8.3 Migraine Drugs Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Migraine Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Migraine Drugs by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Migraine Drugs by Type (2021-2026)
• 10.2 Migraine Drugs Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Migraine Drugs by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Migraine Drugs by Application (2021-2026)
• 10.3 Migraine Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Migraine Drugs by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Migraine Drugs by Region (2021-2026)
• 10.4 North America Migraine Drugs Estimates and Projections (2021-2026)
• 10.5 Europe Migraine Drugs Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Migraine Drugs Estimates and Projections (2021-2026)
• 10.7 Latin America Migraine Drugs Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Migraine Drugs Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List